Evidence map›Paper›PMID 37549344›Full record

ReviewCanadian Urological Association journal = Journal de l'Association des urologues du Canada2023

Current advances in pain regimens for percutaneous nephrolithotomy A comprehensive review.

Tomas Paneque, John Richey, Ahmad Abdelrazek, Kevin Morgan, Joseph Fitz-Gerald, Seth Swinney, Zachary M Connelly, Nazih Khater

Open access · diamondAbstract readReview
In one paragraph

Review in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. The efficacy of 0.25% bupivacaine infiltration in tubeless percutaneous nephrolithotomy in singular stone of the pelvis: A randomized clinical trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tomas PanequeDepartment of Urology, LSU Health Shreveport, Shreveport, LA, United States.
John RicheyLSU Health Shreveport School of Medicine, Shreveport, LA, United States.
Ahmad AbdelrazekMayo Clinic, Rochester, Rochester, MN, United States.
Kevin MorganDepartment of Urology, LSU Health Shreveport, Shreveport, LA, United States.
Joseph Fitz-GeraldDepartment of Urology, LSU Health Shreveport, Shreveport, LA, United States.
Seth SwinneyDepartment of Urology, LSU Health Shreveport, Shreveport, LA, United States.
Zachary M ConnellyLSU Health Shreveport School of Medicine, Shreveport, LA, United States.
Nazih KhaterDepartment of Urology, LSU Health Shreveport, Shreveport, LA, United States.
Louisiana State University Health Sciences Center Shreveport · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPercutaneous nephrolithotomy (PCNL) causes pain and discomfort after surgery. The primary causes of immediate postoperative pain after PCNL are visceral pain from the ureters and kidneys, and body surface discomfort from incisions. Acute, untreated pain has the potential to develop into chronic pain, which remains a considerable burden for the rehabilitation of patients. The goal of this review was to describe the current options for treating pain post-PCNL.

methodsWe conducted a literature review of all published manuscripts on pain protocols for patients undergoing PCNL and related topics; 50 published manuscripts were identified and reviewed.

resultsPCNL morbidity must be reduced by an appropriate management of postoperative pain. Opioids, multimodal therapy, tubeless PCNL, reduced size of nephrostomy tube, and regional anesthesia are currently available for reducing postoperative pain.

conclusionsImplementing successful treatment strategies for postoperative pain after PCNL is key in reducing the morbidity and mortality of PCNL.

Identifiers

PMID37549344
PMCPMC10657229
OpenAlexW4385680794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.